PAR-23-235: National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
Closed
This grant is closed. A newer notice from the same program is forecast: National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) (PAR-27-105). Status: Expected deadline January 25, 2027. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on September 7, 2026.
From the official notice on Grants.gov, last changed July 28, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP41
- Clinical trialsOptional
- Funded byNIBIB
- Median yearly award$312,965
- Typical project length10 years
- P41, Biotechnology Resource Grant. A national resource that develops technology and makes it available to researchers. Other open P41 notices.
Projects funded under PAR-23-235 were run by National Institute of Biomedical Imaging and Bioengineering (NIBIB, 12 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-235 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-27-105 | June 9, 2026 | Expected deadline January 25, 2027 | Forecast |
Key dates
| Posted | July 28, 2023 |
|---|---|
| Deadline | September 7, 2026 |
| Archived by Grants.gov | October 13, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (76% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. BTRCs also make their technologies available to other investigators, train members of the research community in the use of the technologies, and disseminate the technologies broadly.
Funded under PAR-23-235 so far
NIH funded 12 projects under PAR-23-235 in fiscal 2024 to 2026, at 12 institutions. The median yearly award was $312,965.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Microsystems-Based Imaging Systems | University of Michigan at Ann Arbor | 2026 | $1.3 million |
| Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT) | Brigham and Women's Hospital | 2026 | $1.6 million |
| Combined-Therapy Protocols for Cognitive/Behavioral Disorders | Albany Research Institute, Inc. | 2026 | $367,355 |
| ReproNim: A Center for Reproducible Neuroimaging Computation | Univ of Massachusetts Med Sch Worcester | 2026 | $88,698 |
| Administration | Stanford University | 2026 | $117,390 |
| TR&D 3: Revealing Microstructure: Biophysical Modeling and Validation for Discovery and Clinical Care | New York University School of Medicine | 2026 | $341,448 |
| Administrative Core | University of Kansas Lawrence | 2026 | $568,652 |
| TR&D3 - Rapid Translation of AI-powered Temporally Precise mHealth Interventions via Efficient and Embeddable Trustworthy Biomarker Implementations | University of Memphis | 2026 | $300,572 |
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before
From fiscal 2021 to 2025, Discovery and Applied Research for Technological Innovations to Improve Human Health (93.286) awarded $1.8 billion across 1,983 grant awards, an average of $886,380 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Massachusetts | 75 | $83.5 million |
| The Johns Hopkins University | Maryland | 68 | $83.5 million |
| The Leland Stanford Junior University | California | 64 | $53.0 million |
| Brigham & Womens Hospital Inc | Massachusetts | 41 | $49.5 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 44 | $48.3 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PAR-27-105, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-235 still open?
No. It closed on September 7, 2026. A newer notice is forecast: PAR-27-105, expected deadline January 25, 2027.
Who can apply for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)?
Closed September 7, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-23-235?
NIH RePORTER lists 12 projects funded under PAR-23-235 in fiscal 2024 to 2026, at 12 institutions. The most were at University of Michigan at Ann Arbor, Brigham and Women's Hospital, Albany Research Institute, Inc.
Who has won Discovery and Applied Research for Technological Innovations to Improve Human Health grants before?
The largest recipients over five fiscal years were The General Hospital Corporation, The Johns Hopkins University, The Leland Stanford Junior University. The program made 1,983 awards worth $1.8 billion in that time.
Similar open grants
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)